These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20598)

  • 21. [The effect of various beta 2-adrenergic bronchodilator agents in CARD patients].
    Kreukniet J
    Ned Tijdschr Geneeskd; 1977 Jun; 121(23):936-40. PubMed ID: 876421
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of cardiorespiratory effects of rimiterol and terbutaline aerosols.
    Harris L
    Bull Physiopathol Respir (Nancy); 1974; 10(6):801-10. PubMed ID: 4156915
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report.
    König P; Gayer D; Barbero GJ; Shaffer J
    Pediatr Pulmonol; 1995 Oct; 20(4):205-14. PubMed ID: 8606849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
    Boonsawat W; Goryachkina L; Jacques L; Frith L
    Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structural basis of airways hyperresponsiveness in asthma.
    Stănescu DC
    J Appl Physiol (1985); 2006 Dec; 101(6):1812; author reply 1813. PubMed ID: 16931560
    [No Abstract]   [Full Text] [Related]  

  • 26. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma.
    Spector SL; Nicodemus CF; Corren J; Schanker HM; Rachelefsky GS; Katz RM; Siegel SC
    J Allergy Clin Immunol; 1995 Aug; 96(2):174-81. PubMed ID: 7636054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma.
    Patel KR
    Br J Clin Pharmacol; 1986 Feb; 21(2):234-7. PubMed ID: 3513811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annals of allergy.
    Leifer KN; Wittig HJ
    Ann Allergy; 1975 Aug; 35(2):69-80. PubMed ID: 238436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
    Nightingale JA; Rogers DF; Barnes PJ
    Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-acting inhaled beta 2-agonists in the management of asthma: recent advances and current recommendations.
    Redington AE; Rees PJ
    Int J Clin Pract; 1998 Oct; 52(7):482-6. PubMed ID: 10622090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic.
    Ulrik CS; Kok-Jensen A
    Eur Respir J; 1994 May; 7(5):1003-5. PubMed ID: 7914175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of salmeterol in patients with allergic bronchial asthma].
    Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
    Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
    Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
    Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.
    Tattersfield AE; Löfdahl CG; Postma DS; Eivindson A; Schreurs AG; Rasidakis A; Ekström T
    Lancet; 2001 Jan; 357(9252):257-61. PubMed ID: 11214127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchodilating effect of formoterol but not of salmeterol in two asthmatic patients.
    Noppen M; Vincken W
    Respiration; 2000; 67(1):112-3. PubMed ID: 10705276
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypokalaemic effect of salbutamol and terbutaline in bronchial asthma.
    Narang NK; Meratwal S; Toshniwal GL
    J Assoc Physicians India; 1991 Mar; 39(3):301-2. PubMed ID: 1880120
    [No Abstract]   [Full Text] [Related]  

  • 38. Bronchodilator response as a marker of poor asthma control.
    Heffler E; Crimi C; Campisi R; Sichili S; Nicolosi G; Porto M; Intravaia R; Sberna ME; Liuzzo MT; Crimi N
    Respir Med; 2016 Mar; 112():45-50. PubMed ID: 26823211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unreliability of maximum mid-expiratory flow rate as sole index of bronchodilator response in chronic asthma.
    Leifer KN; Wittig HJ
    Ann Allergy; 1977 Feb; 38(2):96-100. PubMed ID: 842901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the bronchodilator effect of oral fenoterol and ephedrine in asthmatic children.
    McLaughlin ET; Bethea LH; Wittig HJ
    Ann Allergy; 1982 Oct; 49(4):191-5. PubMed ID: 7125306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.